Nov 012023
Drug Name |
Active Ingredient(s) |
Approval Date |
FDA-Approved Use on Approval Date |
Press Release |
Drug Trials Snapshot |
| Loqtorzi | toripalimab-tpzi | 10/27/2023 | To treat recurrent or metastatic nasopharyngeal carcinoma when used together with or following other therapies | ||
| Omvoh | mirikizumab-mrkz | 10/26/2023 | To treat ulcerative colitis | Drug Trials Snapshot | |
| Agamree | vamorolone | 10/26/2023 | To treat Duchenne muscular dystrophy | Drug Trials Snapshot | |
| Bimzelx | bimekizumab | 10/17/2023 | To treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy | Drug Trials Snapshot | |
| Zilbrysq | zilucoplan | 10/17/2023 | To treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor (AChR) antibody positive | ||
| Velsipity | etrasimod | 10/12/2023 | To treat moderately to severely active ulcerative colitis in adults |
Sorry, the comment form is closed at this time.